AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Evogene Ltd. Report Publication Announcement 2021

Nov 10, 2021

6785_rns_2021-11-10_b7c108c6-45af-48d8-937e-438935f35e0e.htm

Report Publication Announcement

Opens in your device viewer

_________ false


�� "�	2 381
EVOGENE LTD
Corporation no: 512838723	13041
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	10/11/2021
	www.isa.gov.il			www.tase.co.il				Reference:	2021-02-165093	Time of broadcast: 13:37 13:37

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


	The corporation is a foreign private issuer as defined by U.S. Securities Laws.


Attached hereto is a report on	Evogene Announces Participation in the Second Research Period of the CRISPR-IL Consortium

PR_Evogene_CRISPR-IL_2_FINAL_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: -1	Date of revision of form structure: 19/10/2021
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121 , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected] Company site: www.evogene.com

Previous names of reporting entity:

Name of the Signatory: Kofman Guy Position of Signatory in the reporting corporation: Lawyer/ Legal Counsel Name of Employer Company:
Address: Gad Feinstein St. 13 , Rehovot 7638517 Telephone: 08-9311962 Facsimile: 08-9466724 E-mail: [email protected] 1